Skip to main content
OCUL logo
OCUL
(NASDAQ)
Ocular Therapeutix, Inc.
$8.49-- (--)
Loading... - Market loading

Ocular Therapeutix (OCUL) Stock Price & Financial Analysis

Ocular Therapeutix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.09 - $8.73
52-Week High$16.44
52-Week Low$5.80
Open$8.09
Volume4.37M
Average Volume (3M)4.37M
Market Cap1.59B
Shares Outstanding187.24M
Price to Sales (P/S)30.02
Price to Book (P/B)2.38
EV/EBITDA-3.59
Revenue (TTM)51.95M
Net Income (TTM)-265.94M
Free Cash Flow (TTM)-216.89M
EPS (TTM)$-1.19
Profit Margin-511.90%
Operating Margin-519.75%
Return on Equity (ROE)-40.64%
Debt to Equity0.11
50-Day MA$9.10
200-Day MA$11.10
52-Week Change27.37%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ocular Therapeutix

What is the current stock price for OCUL?

As of the latest trading session, OCUL stock trades at $8.49. The 52-week range is $5.80–$16.44, with a day range of $8.09–$8.73.

What is the P/E ratio for OCUL?

The P/E ratio (Price-to-Earnings) for OCUL is shown in the Key Statistics section. This valuation metric helps compare Ocular Therapeutix, Inc. to industry peers.

Does OCUL pay dividends?

Ocular Therapeutix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCUL?

Based on 3 analysts, the consensus for OCUL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OCUL?

Ocular Therapeutix's market capitalization is $1.59B, classifying it as a small-cap company. Ocular Therapeutix operates in the Healthcare sector within the Biotechnology industry.